Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Optimizing Management and Medication of Febrile Children in Out-of-hours Primary Care: CHILI Cluster RCT (CHILI)

15 de septiembre de 2016 actualizado por: Maastricht University Medical Center

Optimizing Management and Medication of Febrile Children in Out-of-hours Primary Care: the CHILI Cluster Randomised Trial

The CHILI cluster randomised controlled trial (RCT) will investigate whether the use of an interactive information booklet during consultations for febrile children at General Practice (GP) out-of-hours centres can reduce the number of antibiotic prescriptions, improve parental satisfaction and reduce intention to reconsult for childhood fever episodes.

Descripción general del estudio

Estado

Terminado

Descripción detallada

A GP-parent information exchange tool in the form of an interactive booklet has the potential to provide parents with information about symptoms and fever management and consistent information during GP consultations. Thereby enhancing their self-management and providing them with safety net advice when they return home.

It is hypothesized that the use of such an interactive booklet during consultations for febrile children at GP out-of-hours centres will result in a reduced number of antibiotic prescriptions, improved parental satisfaction and reduced intention to re-consult.

The development of the interactive booklet concerned a three-stage process and is based on extensive qualitative work among parents, GPs and other professionals involved in childhood fever management. The booklet incorporates already existing information about fever, alarm symptoms, advice on use of medication and specific infectious diseases that frequently occur in childhood in combination with fever such as upper respiratory tract infections, and otitis media.

We will perform a cluster-randomised controlled trial at 20 GP out-of-hours centres in the Netherlands. GP out-of-hours centres will be stratified by size, to ensure equal distribution of size between the intervention and control group. The required number of clusters and participants was based on the following assumptions: (1) ICC of 0.01, (2) alpha of 0.05, power of 0.80, (3) proportion of antibiotic prescriptions in control group of 25% and a proportion of 19% in the intervention group (6% minimal clinical relevant difference) and (4) 10% loss to follow-up and 10% efficiency loss based on unequal cluster sizes. Based on a previous cohort study, we estimated to include 1000 children per cluster (GP out-of-hours centre) within six months, resulting in a need for 20 clusters and an effective sample size of 737 patients in the intervention and control group (1474 in total).

The booklet will be used during consultations with febrile children at the GP out-of-hours centres that are randomly allocated by computer to the intervention. The child's symptoms will determine which information and advice parents receive from the GP.

Statistical analysis will be performed based on intention to treat principle by performing multilevel logistic regression analysis using IBM SPSS version 21.0 and MLwiN software. We will determine independent factors associated with antibiotic prescriptions. The same will be done for secondary outcomes.

All data will be obtained, managed and monitored according to the guidelines of Good Clinical Practice.

Tipo de estudio

Intervencionista

Inscripción (Actual)

1262

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Limburg
      • Maastricht, Limburg, Países Bajos, 6229 HA
        • Maastricht University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

3 meses a 12 años (Niño)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Age between three months and twelve years
  • GP decides this is a fever-related consultation

Exclusion Criteria:

  • Age under 3 months or over 12 years
  • GP decides this is NOT a fever-related consultation

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Doble

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Intervention
All GPs working at the participating GP out-of-hours centres that are in the intervention group will use the GP-parent information-exchange tool (interactive booklet).
The booklet incorporates already existing information about fever, alarm symptoms, advices use of medication and specific infectious diseases that frequently occur in childhood in combination with fever such as upper respiratory tract infections, and otitis media. The difference with these existing sources of information is the fact that they until now, were not incorporated into one booklet which can be physically handed over to parents.
Otros nombres:
  • Interactive booklet
Sin intervención: Control
All GPs working at the participating GP out-of-hours centres that are in the control group will provide care as usual.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Antibiotic Prescription
Periodo de tiempo: Baseline (Initial consultation)
Antibiotic prescriptions for febrile children in GP out-of-hours centres during the initial consultation (dichotomous scale; number of participants with an antibiotic prescription).
Baseline (Initial consultation)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Intention to re-consult
Periodo de tiempo: Asked within two weeks after initial consultation
Intention to re-consult for similar illnesses among parents, number of parents with the intention to re-consult
Asked within two weeks after initial consultation
Parental satisfaction with care
Periodo de tiempo: Asked within two weeks after initial consultation
VAS scale 1-10
Asked within two weeks after initial consultation
Self-reported adverse events related to the fever episode like hospital admission
Periodo de tiempo: Asked within two weeks after initial consultation
Asked within two weeks after initial consultation
Antibiotic prescription rates at re-consultations
Periodo de tiempo: Asked within two weeks after initial consultation
Prescription rates at re-consultations for the same illness episode (defined as a consultation for the same reason over the last two weeks)
Asked within two weeks after initial consultation
Consultation rates
Periodo de tiempo: During complete study period, during 6 months of study completion
Consultation rates of fever related consultations of children below the age of 12 years between intervention and control groups, through 6 months of study completion.
During complete study period, during 6 months of study completion
Referral to secondary care
Periodo de tiempo: Baseline (during initial consultation)
Number of participants with Referral to secondary care during initial consultation
Baseline (during initial consultation)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Eefje de Bont, MD, MSc, Research Institute CAPHRI, Department of Family Medicine, Maastricht University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de noviembre de 2015

Finalización primaria (Actual)

1 de junio de 2016

Finalización del estudio (Actual)

1 de junio de 2016

Fechas de registro del estudio

Enviado por primera vez

26 de octubre de 2015

Primero enviado que cumplió con los criterios de control de calidad

30 de octubre de 2015

Publicado por primera vez (Estimar)

3 de noviembre de 2015

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

16 de septiembre de 2016

Última actualización enviada que cumplió con los criterios de control de calidad

15 de septiembre de 2016

Última verificación

1 de octubre de 2015

Más información

Términos relacionados con este estudio

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir